Extended spectrum beta-lactamase producing bacteria: Molecular studies and the effects of local remedies
Ohalete Chinyere Ngozi, Obiajuru I O C and Amadi E S
Imo State University, Nigeria
Federal University of Technology, Nigeria
: J Virol Antivir Res
Abstract
Molecular studies of ESβL-producing bacteria isolated from clinical samples was determined as well as the effects of medicinal plants on the isolates. Antimicrobial resistance profile was determined by the Kirby-Bauer technique. Phenotypic expression of β-lactamases production was performed by the double disk diffusion method. Genomic DNA extraction was by alkaline lysis method and hybridization effected with primers of the three β-lactamases genes, TEM, SHV and CTX-M. The isolated DNA and plasmids were analyzed by the agarose gel electrophoresis. Extraction of the active components from plant material was conducted. Effects of the plant extracts on ESβL producing bacteria and the minimum inhibitory concentration were also determined. The results of screening the isolates with 12 antimicrobials showed that the isolates expressed high resistance rates. Examination of clinical samples showed higher prevalence of multiple antibiotic resistant (MAR) Escherichia coli (50.3%) than P. aeruginosa (43.3%) and Klebsiella species (36.6%). The prevalence of ESβL-producing isolates was highest (67.6%) amongst E. coli than Klebsiella species (64.7%) and P. aeruginosa (57.7%). Gel electrophoresis of the amplified (PCR) genomic products showed that 36.7% were positive for TEM, 66.7% for SHV and 23.3% for CTX-M genes. The highest growth inhibitory effect was exhibited on E. coli and Klebsiella species by, Ocimum gratissimum and on Escherichia coli by Xylopia aethiopica. The minimal inhibitory concentrations of the selected medicinal plant extracts on the test bacterial isolates were higher for ESβL-bacteria than for non-resistant isolates. Extracts of commonly used medicinal plants in Imo State, Nigeria, such as those used in the present study are capable of inhibiting growth of MAR and ESβL-producing bacteria. Therefore there is need for further investigations in terms of toxicological studies and purification of active components with a view to exploiting the plants in novel drug development.